A study that surveyed cancer screening data included in medical journals worldwide from January 2020 into December 2021 showed significant decreases in the number of screenings for breast, colorectal and cervical cancers during the early phase of the COVID-19 pandemic. The findings of the study, published in JAMA Oncology, are one point of evidence that the global pandemic widely affected cancer screening services.